Glucophage en es it fr

Glucophage Brand names, Glucophage Analogs

Glucophage Brand Names Mixture

  • No information avaliable

Glucophage Chemical_Formula


Glucophage RX_link

Glucophage fda sheet

Glucophage FDA

Glucophage msds (material safety sheet)

Glucophage MSDS

Glucophage Synthesis Reference

No information avaliable

Glucophage Molecular Weight

211.215 g/mol

Glucophage Melting Point

300 oC

Glucophage H2O Solubility

1000 mg/L

Glucophage State


Glucophage LogP


Glucophage Dosage Forms

Liquid for injection; Tablets for oral use (125 mg, 250 mg, or 500 mg)

Glucophage Indication

For use in the treatment of hypertension.

Glucophage Pharmacology

Methyldopa is an aromatic-amino-acid decarboxylase inhibitor in animals and in man. Only methyldopa, the L-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues of norepinephrine. In man the antihypertensive activity appears to be due solely to the L-isomer. About twice the dose of the racemate (DL-alpha-methyldopa) is required for equal antihypertensive effect. Methyldopa has no direct effect on cardiac function and usually does not reduce glomerular filtration rate, renal blood flow, or filtration fraction. Cardiac output usually is maintained without cardiac acceleration. In some patients the heart rate is slowed. Normal or elevated plasma renin activity may decrease in the course of methyldopa therapy. Methyldopa reduces both supine and standing blood pressure. Methyldopa usually produces highly effective lowering of the supine pressure with infrequent symptomatic postural hypotension. Exercise hypotension and diurnal blood pressure variations rarely occur.

Glucophage Absorption

Absorption from the gastrointestinal tract is variable but averages approximately 50%.

Glucophage side effects and Toxicity

The oral LD50 of methyldopa is greater than 1.5 g/kg in both the mouse and the rat. Symptoms of overdose include bloating, constipation, diarrhea, dizziness, extreme drowsiness, gas, light-headedness, nausea, severely low blood pressure, slow heartbeat, vomiting, and weakness.

Glucophage Patient Information

No information avaliable

Glucophage Organisms Affected

Humans and other mammals